Resideo CEO Buys 15,000 Shares as REZI Slides Below $20
Thomas Surran spent $306,900 on Resideo stock at $20.46 a share, taking his direct holding to 338,573 shares — then watched the stock close nearly 5% lower on Monday.

Resideo chief executive Thomas Surran purchased 15,000 company shares at $20.46 apiece for $306,900, lifting his direct stake to 338,573 shares worth roughly $6.9 million as of the market close.
Resideo Technologies (ticker: REZI) chief executive Thomas Surran has put his own money behind the company he runs, buying 15,000 shares on the open market at $20.46 each — a $306,900 outlay that lifts his direct holding to 338,573 shares.
The purchase, detailed in a filing summarized by Motley Fool, values Surran's direct stake at roughly $6.9 million as of the market close. That valuation is consistent with the full 338,573-share position marked at the same $20.46 price he paid — an arithmetic check that suggests the buy was executed close to where the stock was changing hands at the time.
The stock did not cooperate on the day
Timing, as always with insider buying, is a matter of luck as much as judgment. Resideo shares last traded at 19.28 in the session ended Mon, 24 Aug 2026 at 20:00 GMT, down 4.88% from the prior close of 20.27, with a day range of 19.27 to 20.63. The low of the day was the closing print, which is rarely a sign of buyers stepping in late.
That leaves the executed price of $20.46 above where the shares finished. On an illustrative basis, the gap between the purchase price and the closing level works out to roughly 5.8% — meaning the position was underwater almost immediately in mark-to-market terms. Insiders do not typically buy for a day trade, and a filing of this kind is best read as a statement about a multi-quarter view rather than a call on the next print. But the optics of a chief executive stepping in just as the tape breaks lower are worth noting.
The broader market offered little cover. The S&P 500, tracked by SPY, closed at $763.47, down 0.29% on the day, and the Nasdaq 100 proxy QQQ fell 1.00% to $706.32. The Dow 30 tracker DIA was the outlier, up 0.27% at $533.65. Against that backdrop, a near-5% single-day decline in Resideo is a company- or sector-specific move, not a beta story.
What an open-market buy actually signals
There is a meaningful difference between the kinds of transactions that appear in insider filings. Shares acquired through option exercises, restricted stock vesting, or an employee purchase plan tell you little — they are compensation mechanics, and they happen on a calendar rather than on conviction. An open-market purchase, paid for in cash at a price the executive did not choose, is the category that investors watch, because the buyer had the option of doing nothing and chose otherwise.
Surran's transaction falls into that second category. The 15,000 shares bought represent roughly 4.4% of his resulting 338,573-share direct position on an illustrative calculation — an incremental addition rather than a wholesale change in exposure, but a real one. The dollar figure, $306,900, is large enough to be a considered decision and small enough that it does not, by itself, transform his economic alignment with shareholders.
Two caveats belong with any read of this data. First, insider buying is a noisy signal at the single-transaction level; academic work on the subject generally finds the signal strengthens in clusters, when multiple officers and directors buy in the same window. Nothing in the available filing detail tells us whether other Resideo insiders were active alongside him. Second, executives buy for reasons that have nothing to do with a valuation view — meeting internal share-ownership guidelines is a common one at companies that impose them.
Why the price paid is the number to keep
The most durable piece of information in a filing like this is not the share count but the price. It marks a level at which the person with the fullest view of the business was willing to commit personal capital. For anyone tracking Resideo, $20.46 becomes a reference point: a price that a well-informed buyer accepted, and one the market has since traded through to the downside.
The most durable piece of information in a filing like this is not the share count but the price.
That reference matters more when a stock has been weak. The last close of 19.28 sits below both the purchase price and the prior session's 20.27, and the day's high of 20.63 shows the shares did trade above the executed level at some point during the session before giving it all back. Whether that pattern repeats is the immediate question for holders.
The size of Surran's direct stake also puts the buy in perspective. At 338,573 shares, his holding is substantial relative to the transaction — meaning the day's decline cost his existing position considerably more on paper than the $306,900 he just deployed. Executives with large stakes are already exposed to the share price; adding to them is, in that sense, doubling down rather than establishing a view.
What to watch from here
Several things would sharpen the picture. Additional filings from other Resideo officers or directors in the same window would turn a single data point into a cluster, which is the version of this signal that historically carries more weight. Conversely, disclosed sales by other insiders would cut against it.
The second thing to watch is whether the stock stabilizes near the level Surran paid. A quick recovery back through $20.46 would validate the timing; continued weakness below the day's 19.27 low would tell a different story about what the market is pricing that the filing does not address.
Third, the next scheduled company disclosure — earnings, guidance, or any strategic update — will provide the operating context that an insider filing cannot. A purchase made shortly before a results date is subject to trading-window rules, and the fact that the transaction was permitted at all implies the executive was not inside a blackout period at the time.
For now, the facts are narrow but clean: a chief executive spent $306,900 of his own money on 15,000 shares at $20.46, took his direct stake to 338,573 shares worth roughly $6.9 million at the marks used in the filing summary, and saw the stock close the day at 19.28 after a 4.88% decline. Everything beyond that — including whether the buy proves well-timed — remains an open question that the next few sessions and the next earnings report will begin to answer.
Key facts
- Insider transaction: Thomas Surran, CEO, bought 15,000 Resideo shares at $20.46
- Total outlay: $306,900
- Resulting direct stake: 338,573 shares, roughly $6.9 million
- REZI last close: 19.28, -4.88%, as of Mon, 24 Aug 2026 20:00 GMT
Frequently asked questions
How many Resideo shares did the CEO buy and at what price?
Thomas Surran, chief executive of Resideo, purchased 15,000 shares at $20.46 per share. The transaction totaled $306,900. Following the buy, his direct holdings rose to 338,573 shares, a stake valued at roughly $6.9 million as of the market close reported in the filing summary.
Where did Resideo stock close on the day of the disclosure?
Resideo shares last traded at 19.28 as of Mon, 24 Aug 2026 at 20:00 GMT, down 4.88% from the prior close of 20.27. The day range ran from 19.27 to 20.63, meaning the stock finished at its session low, below the $20.46 price the chief executive paid.
Why do investors pay attention to open-market insider purchases?
Open-market purchases involve an executive spending personal cash at a market-set price, which distinguishes them from option exercises or restricted stock vesting that occur automatically as compensation. Because the buyer could have done nothing instead, such transactions are read as a voluntary expression of confidence, though a single purchase is a noisy signal on its own.
Does one insider buy reliably predict a rising share price?
No. Research on insider transactions generally finds the signal is stronger when several officers and directors buy within the same window, forming a cluster. A single purchase can also reflect internal share-ownership requirements rather than a valuation judgment, so it should be weighed against operating results and other disclosures.
How did the broader market perform that session?
The S&P 500 tracker SPY closed at $763.47, down 0.29%, while the Nasdaq 100 proxy QQQ fell 1.00% to $706.32. The Dow 30 tracker DIA rose 0.27% to $533.65. Resideo's near-5% decline was therefore far larger than the general market move that day.
What should investors watch next on Resideo?
Key items include whether other Resideo officers or directors file purchases in the same window, which would strengthen the signal; whether the share price recovers back above the $20.46 level the chief executive paid; and the company's next scheduled earnings or guidance update, which supplies the operating context a filing alone cannot.
Sources
- Resideo CEO Thomas Surran Buys 15,000 Shares at $20.46 — Motley Fool
Photo: HUUM │sauna heaters · Pexels Licence — source


